Related Experiment Videos
Double blind test with mianserin versus chlorimipramine
Advances in Biochemical Psychopharmacology
|January 1, 1982
Summary
Mianserin demonstrates antidepressant efficacy comparable to chlorimipramine but with fewer adverse effects. This study suggests mianserin may modulate endorphinergic activity, impacting brain function in depression treatment.
Area of Science:
- Psychiatry
- Neuroscience
- Pharmacology
Background:
- Depression is a prevalent mood disorder requiring effective pharmacological treatments.
- Mianserin and chlorimipramine are established antidepressants with different side effect profiles.
- The role of endorphins in antidepressant action requires further elucidation.
Purpose of the Study:
- To compare the efficacy and side effect profiles of mianserin and chlorimipramine in treating depression.
- To investigate the potential impact of mianserin on electrodermal responses and plasmatic beta-endorphin levels.
Main Methods:
- A double-blind study involving two groups of 30 depressed patients.
- Electrodermal response testing to acoustic stimuli.
- Measurement of plasmatic beta-endorphin levels before and after mianserin treatment.
Main Results:
- Mianserin exhibited antidepressant effects similar to chlorimipramine.
- Mianserin was associated with fewer side effects compared to chlorimipramine.
- A significant decrease in plasmatic beta-endorphin levels was observed after mianserin treatment.
Conclusions:
- Mianserin is an effective antidepressant with a favorable side effect profile.
- The observed decrease in beta-endorphin suggests a potential mechanism of action involving the endorphinergic system.
- Further research into mianserin's effect on brain activity and endorphin modulation is warranted.